Literature DB >> 30148412

Application of drug delivery systems for the controlled delivery of growth factors to treat nervous system injury.

Fukai Ma1, Fan Wang1,2, Ronggang Li1,3, Jianhong Zhu1.   

Abstract

Nervous system injury represent the most common injury and was unique clinical challenge. Using of growth factors (GFs) for the treatment of nervous system injury showed effectiveness in halting its process. However, simple application of GFs could not achieve high efficacy because of its rapid diffusion into body fluids and lost from the lesion site. The drug delivery systems (DDSs) construction used to deliver GFs were investigated so that they could surmount its rapid diffusion and retain at the injury site. This study summarizes commonly used DDSs for sustained release of GFs that provide neuroprotection or restoration effects for nervous system injury.

Entities:  

Keywords:  drug delivery systems; growth factors; nervous system injury; neurogenesis

Mesh:

Substances:

Year:  2018        PMID: 30148412      PMCID: PMC6300096          DOI: 10.1080/15476278.2018.1491183

Source DB:  PubMed          Journal:  Organogenesis        ISSN: 1547-6278            Impact factor:   2.500


  39 in total

1.  US Food and Drug Administration/Conformit Europe-approved absorbable nerve conduits for clinical repair of peripheral and cranial nerves.

Authors:  Adina Haug
Journal:  Ann Plast Surg       Date:  2009-06       Impact factor: 1.539

2.  Enhanced proliferation of neural stem cells in a collagen hydrogel incorporating engineered epidermal growth factor.

Authors:  Edgar Y Egawa; Koichi Kato; Makiko Hiraoka; Tadashi Nakaji-Hirabayashi; Hiroo Iwata
Journal:  Biomaterials       Date:  2011-04-11       Impact factor: 12.479

3.  Long-distance growth and connectivity of neural stem cells after severe spinal cord injury.

Authors:  Paul Lu; Yaozhi Wang; Lori Graham; Karla McHale; Mingyong Gao; Di Wu; John Brock; Armin Blesch; Ephron S Rosenzweig; Leif A Havton; Binhai Zheng; James M Conner; Martin Marsala; Mark H Tuszynski
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

Review 4.  Combination therapies in the CNS: engineering the environment.

Authors:  Dylan A McCreedy; Shelly E Sakiyama-Elbert
Journal:  Neurosci Lett       Date:  2012-02-17       Impact factor: 3.046

5.  Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris.

Authors:  E F Unger; L Goncalves; S E Epstein; E Y Chew; C B Trapnell; R O Cannon; A A Quyyumi
Journal:  Am J Cardiol       Date:  2000-06-15       Impact factor: 2.778

6.  Microgels produced using microfluidic on-chip polymer blending for controlled released of VEGF encoding lentivectors.

Authors:  Justin L Madrigal; Shonit N Sharma; Kevin T Campbell; Roberta S Stilhano; Rik Gijsbers; Eduardo A Silva
Journal:  Acta Biomater       Date:  2018-02-02       Impact factor: 8.947

7.  Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats.

Authors:  Qianqian Han; Wenjie Sun; Hang Lin; Wenxue Zhao; Yuan Gao; Yannan Zhao; Bing Chen; Zhifeng Xiao; Wei Hu; Yuan Li; Bo Yang; Jianwu Dai
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

8.  VEGF-loaded microsphere patch for local protein delivery to the ischemic heart.

Authors:  Jonathan Rodness; Anton Mihic; Yasuo Miyagi; Jun Wu; Richard D Weisel; Ren-Ke Li
Journal:  Acta Biomater       Date:  2016-09-12       Impact factor: 8.947

Review 9.  Growth factors and cytokines in wound healing.

Authors:  Stephan Barrientos; Olivera Stojadinovic; Michael S Golinko; Harold Brem; Marjana Tomic-Canic
Journal:  Wound Repair Regen       Date:  2008 Sep-Oct       Impact factor: 3.617

10.  Randomized, controlled clinical trial to evaluate a xenogeneic collagen matrix as an alternative to free gingival grafting for oral soft tissue augmentation.

Authors:  Michael K McGuire; E Todd Scheyer
Journal:  J Periodontol       Date:  2014-03-05       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.